Somite AI is a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, aiming to become the OpenAI of stem cell biology by developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies.
Market
Human cell therapy development
Location
Boston,
MA,
USA
Coinvestors
Khosla Ventures, SciFi VC, Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto Group Ventures, Pitango HealthTech, TechAviv, Harpoon Ventures, Dr. R. Martin Chavez, Fidji Simo